September 23, 2020
Safeguarding our cancer patients, many of whom may have compromised immune systems, has always been a priority at Vanderbilt-Ingram Cancer Center. The ongoing pandemic has made these safeguards more important than ever.
We have implemented additional measures, including mask requirements, physical distancing and special cleaning regimens, to prevent the spread of the coronavirus that causes COVID-19. When possible, we arrange for consultations between physicians and patients to occur remotely with telemedicine technology. We ask that you join us in our efforts to contain the coronavirus by wearing masks properly and following other prevention guidance.
In this issue of Momentum, we provide tips on how to maximize mask protection, and we depict in a photo essay some of our infection control measures. Our efforts are not limited to our clinics. Vanderbilt-Ingram researchers are leading international projects to monitor the effect of SARS-CoV-2 infection on people with cancer and assess outcomes to determine optimal treatments. You can read about their work in this issue.
Our cover story focuses on hereditary prostate cancer and how new research by our investigators sets the stage for physicians to better distinguish which men are at highest risk. Another story details the expanding role of PARP inhibitors for treating different types of cancer. Also, we provide you with information about new treatments for graft-versus-host disease. And we introduce new leaders who are advancing the Vanderbilt-Ingram mission in their new roles as associate directors.
In this issue’s “My Story,” one of our breast cancer researchers shares a first-person account of being diagnosed with the disease she has spent her career studying.
Research discoveries and evidence-based care are critical for a successful path forward in this pandemic. Please wear masks, be safe and care for one another. By working together, we will get through this pandemic, and in the process, continue to make new discoveries that will improve the outcomes and lives of people affected by cancer.